NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

PODD | NASDAQ

$137.20 $0.00 | 0.00%

Next Earnings: Sep 14, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 19.9x
Payout Ratio (TTM):
52-Week Range: $126.40 - $354.88

* Forward PE is based on street estimates.

10 Year PODD Performance Metrics:

Total Return (with DRIP): 232.7% (12.77% CAGR)
Total Return (no DRIP): 232.7% (12.77% CAGR)
Share Price: 232.7% (12.77% CAGR)
Yield on Cost (with DRIP):
Total Invested: $10,000
Total Value (with DRIP): $33,269
Total Return $ (with DRIP): $23,269
PODD Total Return
1Y 2Y 5Y 10Y All
PODD Price Chart
1Y 2Y 5Y 10Y All
DRIPCalc.com
PODD Price

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

PODD Earnings, Revenue, Cash & Debt, Shares Outstanding:

PODD - Revenue
PODD Revenue CAGR:1Y: 23.51%2Y: 28.11%5Y: 24.95%10Y: 24.82%
PODD - Earnings Per Share (EPS)
PODD EPS CAGR:1Y: 328.13%2Y: -27.27%5Y: 0.00%10Y: 0.00%
PODD - Net Income
PODD Net Income CAGR:1Y: 322.22%2Y: -29.03%5Y: 0.00%10Y: 0.00%
PODD - EBITDA
PODD EBITDA CAGR:1Y: 126.03%2Y: 39.80%5Y: 41.41%10Y: 0.00%
PODD - Free Cash Flow
PODD Free Cash Flow CAGR:1Y: -65.72%2Y: -8.92%5Y: 0.00%10Y: 51.44%
PODD - Free Cash Flow / Share
PODD Free Cash Flow / Share CAGR:1Y: -65.21%2Y: -8.42%5Y: 0.00%10Y: 48.56%
PODD - Operating Income
PODD Operating Income CAGR:1Y: 7.10%2Y: 54.13%5Y: 37.59%10Y: 0.00%
PODD - Gross Profit
PODD Gross Profit CAGR:1Y: 24.41%2Y: 30.39%5Y: 25.23%10Y: 27.27%
PODD - Shares Outstanding
PODD Shares Outstanding CAGR:1Y: -1.75%2Y: -3.03%5Y: 0.80%10Y: 1.95%
PODD - Share Buybacks
PODD Share Buybacks CAGR:1Y: 896.68%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PODD - Stock-Based Comp
PODD Stock-Based Comp CAGR:1Y: 161.33%2Y: 7.38%5Y: 16.84%10Y: 13.52%
PODD - Expenses
PODD Expenses CAGR:1Y: 25.00%2Y: 7.92%5Y: 4.56%10Y: 26.59%
PODD - Revenue vs Net Income
PODD - EPS vs FCF / Share
PODD - EPS vs PE Ratio
PODD - FCF vs FCF / Share
PODD - FCF vs Stock Based Comp
PODD - Cash & Debt
PODD - Revenue by Segment
PODD Revenue CAGR:1Y: 23.51%2Y: 28.11%5Y: 24.95%10Y: 24.82%
PODD - Revenue by Region
PODD Revenue CAGR:1Y: 23.51%2Y: 28.11%5Y: 24.95%10Y: 24.82%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

PODD - REVENUE: Actual + Estimates
PODD Actual Revenue CAGR:1Y: 23.51%2Y: 28.11%5Y: 24.95%10Y: 24.82%
PODD - EPS: Actual + Estimates
PODD Actual EPS CAGR:1Y: 328.13%2Y: -27.27%5Y: 0.00%10Y: 0.00%
PODD - NET INCOME: Actual + Estimates
PODD Actual Net Income CAGR:1Y: 322.22%2Y: -29.03%5Y: 0.00%10Y: 0.00%
PODD - EBITDA: Actual + Estimates
PODD Actual EBITDA CAGR:1Y: 126.03%2Y: 39.80%5Y: 41.41%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

PODD - Net Profit Margin
PODD Net Profit Margin CAGR:1Y: 241.50%2Y: -44.60%5Y: 0.00%10Y: 0.00%
PODD - Gross Profit Margin
PODD Gross Profit Margin CAGR:1Y: 0.73%2Y: 1.79%5Y: 0.22%10Y: 1.96%
PODD - Price to Earnings
PODD - Price To Sales Ratio
PODD - Return on Capital Employed
PODD - Return on Invested Capital

Compare stocks side-by-side
 

Projected Future Returns & Dividends for PODD

Based on past 10-year performance, here are PODD growth metrics:

Share price CAGR of +12.77%
Dividend CAGR of +0%

Using PODD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

PODD (DRIP)PODD - No DRIP
Current Price$137.20$137.20
Start Shares72.8972.89
Start Value$10,000$10,000
  
After 10 years:
Final Share Count72.8972.89
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$137.20$137.20
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - PODD

NOTE: Above numbers are our estimate based on PODD's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

Company Info

Insulet Corp. (PODD) had its IPO on 2007-05-15, and is trader on NASDAQ stock exchange.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

PODD website: https://www.insulet.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)